Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03320824 · ClinicalTrials.gov registry record · NA
New Dermal Filler for Lip Augmentation
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 273
- Enrollment target
NCT03320824 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 273 participants.
The verdict
NCT03320824, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 273 participants
- Enrollment target
Study Summary
To demonstrate non-inferiority of Kysse versus a control in lip fullness augmentation
Interventions
- DEVICE New Dermal Filler
- DEVICE Device: FDA Approved Dermal Filler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2017-11-13 |
| Est. Completion | 2019-04-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03320824
The ClinicalTrials.gov registry entry for NCT03320824 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which New Dermal Filler is the first listed.
NCT03320824 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03320824 about?
NCT03320824 is a clinical study titled "New Dermal Filler for Lip Augmentation". To demonstrate non-inferiority of Kysse versus a control in lip fullness augmentation
What is the current status of trial NCT03320824?
This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 2017-11-13. Estimated completion is 2019-04-23.
What interventions are being tested in trial NCT03320824?
The interventions under investigation include: New Dermal Filler (DEVICE), Device: FDA Approved Dermal Filler (DEVICE).
Who is sponsoring clinical trial NCT03320824?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.